SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-174481
Filing Date
2015-05-06
Accepted
2015-05-06 16:06:03
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d902788d10q.htm 10-Q 472948
2 EX-10.1 d902788dex101.htm EX-10.1 501962
3 EX-31.1 d902788dex311.htm EX-31.1 6089
4 EX-31.2 d902788dex312.htm EX-31.2 6090
5 EX-32.1 d902788dex321.htm EX-32.1 2963
6 EX-32.2 d902788dex322.htm EX-32.2 2953
  Complete submission text file 0001193125-15-174481.txt   5922539

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT hptx-20150331.xml EX-101.INS 742769
8 XBRL TAXONOMY EXTENSION SCHEMA hptx-20150331.xsd EX-101.SCH 51833
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hptx-20150331_cal.xml EX-101.CAL 74790
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hptx-20150331_def.xml EX-101.DEF 172644
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hptx-20150331_lab.xml EX-101.LAB 435772
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hptx-20150331_pre.xml EX-101.PRE 300415
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Filer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35614 | Film No.: 15836976
SIC: 2834 Pharmaceutical Preparations